July 28, 2022
Watch Now: Expediting Drug Development – Use of ctDNA as an Early Endpoint
On Wednesday, July 20, Friends of Cancer Research (Friends) hosted a meeting entitled “Expediting Drug Development: Use of ctDNA as an Early Endpoint.” Welcoming everyone, Jeff Allen, President & CEO of Friends, provided updates regarding Friends’ ctDNA for Monitoring Treatment Response (ctMoniTR) project , a unique collaboration exploring whether changes in ctDNA levels can indicate clinical…
Learn More